Taft is a sponsor of the Indiana Life Sciences Conference, “Impact of the New Administration: HHS, FDA, CMS et al.,” which will take place virtually on Feb. 18. The event is part of Indiana University’s Indiana Life Science Collaboration Conference Series.

This conference will outline the new administration’s policies for the health care and life sciences industry, as speakers and panelists discuss the approach to new product approvals, drug pricing, healthcare coverage, and more. Taft partner Neal Roach will give the introduction and Taft partner Mark Shublak will serve as a speaker for the session, “Executive Branch Perspective”.

For more information, or to register for this event, click here.